262 related articles for article (PubMed ID: 31367163)
1. Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis.
Cao J; Kong FH; Liu X; Wang XB
World J Gastroenterol; 2019 Jul; 25(27):3649-3663. PubMed ID: 31367163
[TBL] [Abstract][Full Text] [Related]
2. Effect of dendritic cell-based immunotherapy on hepatocellular carcinoma: A systematic review and meta-analysis.
Chen C; Ma YH; Zhang YT; Zhang F; Zhou N; Wang X; Liu T; Li YM
Cytotherapy; 2018 Aug; 20(8):975-989. PubMed ID: 30072299
[TBL] [Abstract][Full Text] [Related]
3. Autologous transplantation of cytokine-induced killer cells as an adjuvant therapy for hepatocellular carcinoma in Asia: an update meta-analysis and systematic review.
Cai XR; Li X; Lin JX; Wang TT; Dong M; Chen ZH; Jia CC; Hong YF; Lin Q; Wu XY
Oncotarget; 2017 May; 8(19):31318-31328. PubMed ID: 28412743
[TBL] [Abstract][Full Text] [Related]
4. Cytokine-induced killer cell infusion combined with conventional treatments produced better prognosis for hepatocellular carcinoma patients with barcelona clinic liver cancer B or earlier stage: A systematic review and meta-analysis.
Li YC; Zhao L; Wu JP; Qu CX; Song QK; Wang RB
Cytotherapy; 2016 Dec; 18(12):1525-1531. PubMed ID: 27746013
[TBL] [Abstract][Full Text] [Related]
5. TACE combined with dendritic cells and cytokine-induced killer cells in the treatment of hepatocellular carcinoma: A meta-analysis.
He G; Zheng C; Huo H; Zhang H; Zhu Z; Li J; Zhang H
Int Immunopharmacol; 2016 Nov; 40():436-442. PubMed ID: 27716591
[TBL] [Abstract][Full Text] [Related]
6. Dendritic Cell Immunotherapy Combined with Cytokine-Induced Killer Cells Effectively Suppresses Established Hepatocellular Carcinomas in Mice.
Jung NC; Lee JH; Choi HJ; Hwang SU; Song JY; Seo HG; Choi J; Jung SY; Han SG; Lim DS
Immunol Invest; 2016 Aug; 45(6):553-65. PubMed ID: 27410037
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma.
Lee JH; Lee JH; Lim YS; Yeon JE; Song TJ; Yu SJ; Gwak GY; Kim KM; Kim YJ; Lee JW; Yoon JH
Gastroenterology; 2015 Jun; 148(7):1383-91.e6. PubMed ID: 25747273
[TBL] [Abstract][Full Text] [Related]
8. Clinical effect and safety of dendritic cell-cytokine-induced killer cell immunotherapy for pancreatic cancer: a systematic review and meta-analysis.
Liu YL; Yang LX; Zhang F; Tang BS; Zhao LT; Zhu JR; Jin QY; Wang RX; Li YM
Cytotherapy; 2019 Oct; 21(10):1064-1080. PubMed ID: 31462394
[TBL] [Abstract][Full Text] [Related]
9. Intraperitoneal perfusion of cytokine-induced killer cells with local hyperthermia for advanced hepatocellular carcinoma.
Wang XP; Xu M; Gao HF; Zhao JF; Xu KC
World J Gastroenterol; 2013 May; 19(19):2956-62. PubMed ID: 23704829
[TBL] [Abstract][Full Text] [Related]
10. The Efficacy and Safety of Dendritic Cells Co-Cultured with Cytokine-Induced Killer Cell Therapy in Combination with TACE-Predominant Minimally-Invasive Treatment for Hepatocellular Carcinoma: a Meta-Analysis.
Su Y; Yang Y; Ma Y; Zhang Y; Rao W; Yang G; Kou C
Clin Lab; 2016; 62(4):599-608. PubMed ID: 27215078
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the Clinical Efficacy of Dendritic Cell -cytokine Induced Killer Cell-based Adoptive Immunotherapy for Colorectal Cancer.
Xu H; Qin W; Feng H; Song D; Yang X; Zhang J
Immunol Invest; 2021 Aug; 50(6):622-633. PubMed ID: 32718264
[No Abstract] [Full Text] [Related]
12. Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up.
Lee JH; Lee JH; Lim YS; Yeon JE; Song TJ; Yu SJ; Gwak GY; Kim KM; Kim YJ; Lee JW; Yoon JH
Cancer Immunol Immunother; 2019 Jan; 68(1):23-32. PubMed ID: 30232520
[TBL] [Abstract][Full Text] [Related]
13. A meta-analysis of adoptive immunotherapy in postoperative hepatocellular carcinoma.
Zhao H; Zheng M; Wang K; Wang L; He H; Wang M; Shi Y; Huang S; Ji F; Li X; Zhu H; Wang L; Zhang X; Shi X; Zhao S; Fu B; Wu T
J Cancer Res Ther; 2018; 14(4):807-814. PubMed ID: 29970657
[TBL] [Abstract][Full Text] [Related]
14. Cytokine-induced killer cells/dendritic cells-cytokine induced killer cells immunotherapy combined with chemotherapy for treatment of colorectal cancer in China: a meta-analysis of 29 trials involving 2,610 patients.
Zhang L; Mu Y; Zhang A; Xie J; Chen S; Xu F; Wang W; Zhang Y; Ren S; Zhou C
Oncotarget; 2017 Jul; 8(28):45164-45177. PubMed ID: 28404886
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy of DC-CIK combined with sorafenib in the treatment of advanced hepatocellular carcinoma.
Zhou Z; Qin H; Weng L; Ni Y
J BUON; 2019; 24(2):615-621. PubMed ID: 31128014
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients.
Pan K; Li YQ; Wang W; Xu L; Zhang YJ; Zheng HX; Zhao JJ; Qiu HJ; Weng DS; Li JJ; Wang QJ; Huang LX; He J; Chen SP; Ke ML; Wu PH; Chen MS; Li SP; Xia JC; Zeng YX
Ann Surg Oncol; 2013 Dec; 20(13):4305-11. PubMed ID: 23892527
[TBL] [Abstract][Full Text] [Related]
17. CIK cell cytotoxicity is a predictive biomarker for CIK cell immunotherapy in postoperative patients with hepatocellular carcinoma.
Pan QZ; Liu Q; Zhou YQ; Zhao JJ; Wang QJ; Li YQ; Tang Y; Gu JM; He J; Chen SP; Weng DS; Xia JC
Cancer Immunol Immunother; 2020 May; 69(5):825-834. PubMed ID: 32060687
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of cytokine-induced killer cell infusion as an adjuvant immunotherapy for hepatocellular carcinoma: a systematic review and meta-analysis.
Yu R; Yang B; Chi X; Cai L; Liu C; Yang L; Wang X; He P; Lu X
Drug Des Devel Ther; 2017; 11():851-864. PubMed ID: 28360510
[TBL] [Abstract][Full Text] [Related]
19. Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma.
Cui J; Wang N; Zhao H; Jin H; Wang G; Niu C; Terunuma H; He H; Li W
Int J Cancer; 2014 Jan; 134(2):342-51. PubMed ID: 23825037
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data.
Yoon JS; Song BG; Lee JH; Lee HY; Kim SW; Chang Y; Lee YB; Cho EJ; Yu SJ; Sinn DH; Kim YJ; Lee JH; Yoon JH
BMC Cancer; 2019 May; 19(1):523. PubMed ID: 31151419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
